SCHEMBL24317650

SCHEMBL24317650

CCOC(=O)c1ccc(Br)c(N/C=C2\COC(C)(C)OC2=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.44
MAPT P10636 7/20 0.41
KMT2A Q03164 5/20 0.41
RAB9A P51151 5/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
NPC1 O15118 4/20 0.41
KDM4E B2RXH2 3/20 0.39
CYP1A2 P05177 2/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.37
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24315862 0.86 ALDH1A1 (0.53) ALDH1A1MAPTRAB9ASMN1; SMN2KDM4E
SCHEMBL18248923 0.73 CA12 (0.49) ALDH1A1MAPTKMT2ARAB9ASMN1; SMN2
SCHEMBL29426248 0.69 ALDH1A1 (0.52) ALDH1A1RAB9ASMN1; SMN2KDM4ECYP1A2
SCHEMBL17025484 0.69 ALDH1A1 (0.52) ALDH1A1RAB9ASMN1; SMN2KDM4ECYP1A2
SCHEMBL22468902 0.67 CA12 (0.61) ALDH1A1MAPTKMT2ARAB9ASMN1; SMN2
SCHEMBL8107490 0.67 ALDH1A1 (0.77) ALDH1A1MAPTKMT2ARAB9ASMN1; SMN2
SCHEMBL16112294 0.67 RAB9A (0.70) ALDH1A1MAPTKMT2ARAB9ASMN1; SMN2
SCHEMBL29923588 0.67 ALDH1A1 (0.50) ALDH1A1MAPTKMT2ARAB9ASMN1; SMN2
SCHEMBL3633058 0.65 KMT2A (0.64) ALDH1A1MAPTKMT2ARAB9ASMN1; SMN2
SCHEMBL21200870 0.65 ALDH1A1 (0.53) ALDH1A1MAPTKMT2ARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081927-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed